Shares of Inovio Pharmaceuticals (INO) jumped by a staggering 38.93% in 30 days from $6.55 to $9.10 at 20:26 EST on Friday, following the last session’s downward trend. NASDAQ Composite (INO) is rising 0.35% to $14,069.42, following the last session’s upward trend.
Inovio Pharmaceuticals’s last close was $9.15, 72.92% below its 52-week high of $33.79.
Today’s last reported volume for Inovio Pharmaceuticals is 3752936 which is 56.46% below its average volume of 8619901.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 274.5% for the current quarter and 5133.1% for the next. The company’s growth estimates for the present quarter is 69.9% and a drop 300% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.
Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 8.28%, 2.28%, and 3.36%, respectively.
Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.28% (last week), 3.61% (last month), and 3.36% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be oversold (<=20).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $9.10 at 20:26 EST, way under its 52-week high of $33.79 and way above its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s value is way higher than its 50-day moving average of $7.29 and below its 200-day moving average of $9.79.
More news about Inovio Pharmaceuticals (INO).